Harmony Biosciences Holdings, Inc. HRMY Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s total equity?
- Harmony Biosciences Holdings, Inc. (HRMY) reported total equity of $910.35M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s total equity changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s total equity increased by 26.3% year-over-year, from $720.53M to $910.35M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s total equity?
- Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s total equity has grown at a 55.0% compound annual growth rate (CAGR), from $97.18M to $870.22M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.